| 2026 |
Li, L. X., Shahnam, A., Kichenadasse, G., Murray, L., Woodman, R., Abuhelwa, A. Y., . . . Sorich, M. J. (2026). Heterogeneous treatment effect of immune checkpoint inhibitors by pretreatment prognosis in randomized controlled trials. JNCI Cancer Spectrum, 10(2), pkaf127-1-pkaf127-11. DOI Scopus1 WoS1 |
| 2026 |
Abuhelwa, A. Y., Almansour, S. A., Al-Shamsi, H. O., Abuhelwa, Z., Alqudah, M. A. Y., Bustanji, Y., . . . Hopkins, A. M. (2026). Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. Scientific Reports, 16(1), 7683-1-7683-16. DOI |
| 2026 |
Chhetri, R., Modi, N. D., Menz, B. D., Cornelisse, E., Postma, D., Kuderer, N. M., . . . Hopkins, A. M. (2026). Sex-based prognosis in industry-sponsored advanced solid tumour trials: an individual participant data meta-analysis of survival and adverse events. Journal of the National Cancer Institute, 118(7), djag046-1-djag046-10. DOI |
| 2026 |
Chu, B., Modi, N. D., Menz, B. D., Cornelisse, E., Bacchi, S., Bulamu, N., . . . Hopkins, A. M. (2026). Evaluation of Generative Artificial Intelligence Safeguards Against the Creation of Images and Videos Harmful to Public Health. Public Health Reports, 14(4), 542-551. DOI Scopus1 WoS1 Europe PMC1 |
| 2026 |
Menz, B. D., Scarfo, N. L., Modi, N. D., Cornelisse, E., Li, L. X., Tan, J. Q. E., . . . Hopkins, A. M. (2026). Vision-Enabled AI scribes reduce omissions in clinical conversations: evidence from simulated medication histories. npj Digital Medicine, 9(1), 287-11-287-10. DOI |
| 2026 |
Jeong, Y. D., Park, S., Jang, W., Kim, M. S., Bhoomadevi, A., Aalipour, M. A., . . . Ayatollahi, H. (2026). Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. Korean Journal of Internal Medicine, 41(2), 350-366. DOI |
| 2026 |
Stewart, B. W., Marshall, H., Bonevski, B., Griffin, H. J., Hopkins, A. M., Itchins, M., . . . Sitas, F. (2026). The carcinogenicity of e-cigarettes: a qualitative risk assessment. Carcinogenesis, 47(1), bgag015-1-bgag015-14. DOI Scopus6 WoS6 Europe PMC1 |
| 2026 |
Modi, N. D., Alex, C. A., Awaty, A. A., Menz, B. D., Bacchi, S., Gradon, K. T., . . . Hopkins, A. M. (2026). Cross-Sectional Evaluation of Medical Disinformation Safeguards in Consumer-Facing Large Language Model Platforms. JMIR Infodemiology, 6, e89831-1-e89831-5. DOI |
| 2026 |
Tan, J. Q. E., Modi, N. D., Hassankhani, R., Martin, H., Dyk, M. V., Spencer, S., . . . Kichenadasse, G. (2026). Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation. Journal of Oncology Pharmacy Practice, 8 pages. DOI |
| 2025 |
Tan, J. Q. E., Modi, N. D., Hassankhani, R., Martin, H., Dyk, M. V., Spencer, S., . . . Kichenadasse, G. (2025). The Role of Precision Dosing and Therapeutic Drug Monitoring in Precision Oncology: A Single-centre Experience with Everolimus. Journal of Current Oncology, 8(1), 62-71. DOI |
| 2025 |
Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Lyman, G. H., Swain, S. M., . . . Hopkins, A. M. (2025). Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials. International Journal of Cancer, 157(10), 2135-2145. DOI Scopus1 Europe PMC2 |
| 2025 |
Modi, N. D., Li, L. X., Logan, J. M., Wiese, M. D., Abuhelwa, A. Y., McKinnon, R. A., . . . Hopkins, A. M. (2025). The state of individual participant data sharing for the highest-revenue medicines. Clinical Trials, 22(2), 170-177. DOI |
| 2025 |
Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Ruanglertboon, W., Vitry, A., Gao, Y., . . . Hopkins, A. M. (2025). Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models. European Journal of Cancer, 218, 115274-1-115274-6. DOI Scopus27 WoS22 Europe PMC18 |
| 2025 |
Chu, B., Modi, N. D., Menz, B. D., Bacchi, S., Kichenadasse, G., Paterson, C., . . . Hopkins, A. M. (2025). Generative AI’s healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTs. Frontiers in Public Health, 13, 1584348-1-1584348-8. DOI Scopus7 WoS7 Europe PMC3 |
| 2025 |
Modi, N. D., Menz, B. D., Awaty, A. A., Alex, C. A., Logan, J. M., McKinnon, R. A., . . . Hopkins, A. M. (2025). Assessing the system-instruction vulnerabilities of large language models to malicious conversion into health disinformation chatbots. Annals of Internal Medicine, 178(8), 1172-1180. DOI Scopus17 Europe PMC7 |
| 2025 |
Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Li, L. X., Lyman, G. H., Koczwara, B., . . . Hopkins, A. M. (2025). Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer. Cancer Medicine, 14(21), e71320-1-e71320-10. DOI Scopus1 WoS1 Europe PMC2 |
| 2025 |
Modi, N. D. (2025). Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. American College of Cardiology. Journal, online(22), 1-77. DOI Scopus369 WoS330 Europe PMC164 |
| 2024 |
Menz, B. D., Kuderer, N. M., Bacchi, S., Modi, N. D., Chin-Yee, B., Hu, T., . . . Hopkins, A. M. (2024). Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ, 384(e078538), e078538-1-e078538-10. DOI Scopus93 WoS80 Europe PMC48 |
| 2024 |
Modi, N. D., Swain, S. M., Buyse, M., Kuderer, N. M., Rowland, A., Rockhold, F. W., . . . Hopkins, A. M. (2024). Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability. Journal of Clinical Oncology, 42(32), 3773-3777. DOI Scopus6 Europe PMC8 |
| 2024 |
Hopkins, A. M., Modi, N. D., Rockhold, F. W., Hoffmann, T., Menz, B. D., Veroniki, A. A., . . . Sorich, M. J. (2024). Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation. Journal Of Clinical Epidemiology, 167(111263), 1-9. DOI Scopus5 Europe PMC4 |
| 2024 |
Menz, B. D., Modi, N. D., Sorich, M. J., & Hopkins, A. M. (2024). Health disinformation use case highlighting the urgent need for artificial intelligence vigilance: weapons of mass disinformation. JAMA Internal Medicine, 184(1), 92-96. DOI Scopus88 Europe PMC47 |
| 2024 |
Almansour, S. A., Alqudah, M. A. Y., Abuhelwa, Z., Al Shamsi, H. O., Alhuraiji, A., Semreen, M. H., . . . Abuhelwa, A. Y. (2024). Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials. Therapeutic Advances in Medical Oncology, 16, 1-14. DOI Scopus2 Europe PMC1 |
| 2023 |
Modi, N. D., Kichenadasse, G., Hoffmann, T. C., Haseloff, M., Logan, J. M., Veroniki, A. A., . . . Hopkins, A. M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21(1), 400. DOI Scopus22 Europe PMC14 |
| 2023 |
Hopkins, A. M., Modi, N. D., Abuhelwa, A. Y., Kichenadasse, G., Kuderer, N. M., Lyman, G. H., . . . Sorich, M. J. (2023). Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages. JAMA Oncology, 9(12), 1621-1626. DOI Scopus16 Europe PMC15 |
| 2023 |
Modi, N., Abuhelwa, A. Y., Rowland, A., Menz, B. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2023). Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis.. Journal of Clinical Oncology, 41(16_suppl), 530. DOI |
| 2022 |
Modi, N. D., Abuhelwa, A. Y., Mckinnon, R. A., Boddy, A. V., Haseloff, M., Wiese, M. D., . . . Hopkins, A. M. (2022). Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration. JAMA Oncology, 8(9), 1310-1316. DOI Scopus17 Europe PMC17 |
| 2022 |
Tan, E., Abuhelwa, A. Y., Badaoui, S., Modi, N. D., Wiese, M. D., Mckinnon, R. A., . . . Hopkins, A. M. (2022). Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab. Bladder Cancer, 8(1), 81-88. DOI Scopus8 Europe PMC7 |
| 2022 |
Modi, N. D., Danell, N. O., Perry, R. N. A., Abuhelwa, A. Y., Rathod, A., Badaoui, S., . . . Hopkins, A. M. (2022). Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer. ESMO Open, 7(3, article no. 100475), 1-8. DOI Scopus17 Europe PMC14 |
| 2021 |
Modi, N. D., Tan, J. Q. E., Rowland, A., Koczwara, B., Abuhelwa, A. Y., Kichenadasse, G., . . . Hopkins, A. M. (2021). The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data. Npj Breast Cancer, 7(1), 30. DOI Scopus49 Europe PMC37 |
| 2021 |
Modi, N. D., Abuhelwa, A. Y., Menz, B. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2021). Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 12, 732622. DOI Scopus1 Europe PMC1 |
| 2021 |
Modi, N. D., Abuhelwa, A. Y., Badaoui, S., Shaw, E., Shankaran, K., McKinnon, R. A., . . . Hopkins, A. M. (2021). Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib. The Breast, 58, 57-62. DOI Scopus17 Europe PMC10 |
| 2020 |
Ang, F. L. I., Rowland, A., Modi, N. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2020). Early adverse events predict survival outcomes in HER2-positive advanced breast cancer patients treated with Lapatinib plus Capecitabine. Journal of Cancer, 11(11), 3327-3333. DOI Scopus5 WoS5 Europe PMC5 |
| 2020 |
Hopkins, A. M., Wagner, J., Kichenadasse, G., Modi, N., Rowland, A., & Sorich, M. J. (2020). Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy. International Journal of Cancer, 147(11), 3085-3089. DOI Scopus37 Europe PMC29 |
| 2020 |
Modi, N. D., Sorich, M. J., Rowland, A., McKinnon, R. A., Koczwara, B., Wiese, M. D., & Hopkins, A. M. (2020). Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine. Clinical Breast Cancer, 20(2), e220-e228. DOI Scopus15 Europe PMC14 |
| 2020 |
Modi, N. D., Sorich, M. J., Rowland, A., Logan, J. M., McKinnon, R. A., Kichenadasse, G., . . . Hopkins, A. M. (2020). A literature review of treatment-specific clinical prediction models in patients with breast cancer. Critical Reviews in Oncology Hematology, 148(102908), 8 pages. DOI Scopus18 WoS15 Europe PMC13 |
| 2020 |
Modi, N. D., Tan, J. Q. E., Rowland, A., Koczwara, B., Kichenadasse, G., McKinnon, R. A., . . . Hopkins, A. M. (2020). The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data. Frontiers in Oncology, 10(1130), 1130. DOI Scopus13 Europe PMC11 |
| 2019 |
Jin, C., Alenazy, R., Wang, Y., Mowla, R., Qin, Y., Tan, J. Q. E., . . . Ma, S. (2019). Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance. Bioorganic and Medicinal Chemistry Letters, 29(7), 882-889. DOI Scopus17 WoS15 Europe PMC11 |